Latest Expert Opinions

Signal
Opinion
Expert
DON'T BUY
DON'T BUY
July 25, 2006
Prefers CNR (CNR-T) because it is more diversified, both geographically and what they haul. This one is a commodity hauler, making them more exposed to the commodity market. This is the time you want to lighten up in cyclicals.
Prefers CNR (CNR-T) because it is more diversified, both geographically and what they haul. This one is a commodity hauler, making them more exposed to the commodity market. This is the time you want to lighten up in cyclicals.
Norman Levine
Managing Director, Portfolio Management Corp
Price
$55.600
Owned
No
TOP PICK
TOP PICK
July 25, 2006
World's largest generic drug manufacturer. Gone from being a growth stock to a value stock. Merck and Pfizer have come out with their own generics when their drugs came off patent. Based in Israel. The drop in price gives a good opportunity.
World's largest generic drug manufacturer. Gone from being a growth stock to a value stock. Merck and Pfizer have come out with their own generics when their drugs came off patent. Based in Israel. The drop in price gives a good opportunity.
Norman Levine
Managing Director, Portfolio Management Corp
Price
$30.850
Owned
Yes
BUY
BUY
July 25, 2006
All the major drug stocks are starting to act better. In the state of market, money moves from risky stocks to defensive stocks. Has a great yield. A good place to be.
Pfizer Inc (PFE-N)
July 25, 2006
All the major drug stocks are starting to act better. In the state of market, money moves from risky stocks to defensive stocks. Has a great yield. A good place to be.
Norman Levine
Managing Director, Portfolio Management Corp
Price
$24.960
Owned
Yes
BUY
BUY
July 25, 2006
All the major drug stocks are starting to act better. In this type of market, money moves from risky stocks to defensive stocks. A good place to be.
All the major drug stocks are starting to act better. In this type of market, money moves from risky stocks to defensive stocks. A good place to be.
Norman Levine
Managing Director, Portfolio Management Corp
Price
$39.270
Owned
No
BUY
BUY
July 25, 2006
All the major drug stocks are starting to act better. In this type of market, money moves from risky stocks to defensive stocks. A good place to be.
All the major drug stocks are starting to act better. In this type of market, money moves from risky stocks to defensive stocks. A good place to be.
Norman Levine
Managing Director, Portfolio Management Corp
Price
$61.900
Owned
No
BUY
BUY
July 25, 2006
All the major drug stocks are starting to act better. In this type of market, money moves from risky stocks to defensive stocks. A good place to be.
Wyeth (WYE-N)
July 25, 2006
All the major drug stocks are starting to act better. In this type of market, money moves from risky stocks to defensive stocks. A good place to be.
Norman Levine
Managing Director, Portfolio Management Corp
Price
$47.470
Owned
No
BUY
BUY
July 25, 2006
The largest holder of Syncrude. Well-established in the oil sands. Most of its capital expenditures is behind it. Throwing off tons of cash. Very safe place.
The largest holder of Syncrude. Well-established in the oil sands. Most of its capital expenditures is behind it. Throwing off tons of cash. Very safe place.
Norman Levine
Managing Director, Portfolio Management Corp
Price
$33.850
Owned
Yes